Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

OTHER 5 OTHER_GOV 1 INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Thoracic 1 Gastrointestinal 1

Conditions

Carcinoma, Hepatocellular 1

Interventions

Oxaliplatin 30 Capecitabine 26 Fluorouracil 20 Irinotecan 19 tislelizumab 18 apatinib 16 Paclitaxel 13 Cisplatin 13 S 1 (combination) 12 Radiotherapy 12 Leucovorin 11 Bevacizumab 11 Laparoscopy 9 Drug Therapy 9 Cetuximab 9 sintilimab 8 Endoscopic Mucosal Resection 8 Gemcitabine 7 Docetaxel 7 camrelizumab 6 XELOX 6 Surgical Procedures, Operative 6 Radiation 6 Propranolol 6 Nivolumab 6 Neoadjuvant Therapy 6 Immune Checkpoint Inhibitors 6 Folfox protocol 6 Levoleucovorin 5 HMPL-013 5

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

OTHER_GOV × Tyrosine Kinase Inhibitors × Gastrointestinal × Clear all

NCT02794337 2022-04-27

TACE-SBRT

Tata Memorial Hospital

Phase 2/3 Unknown

Gastrointestinal

Carcinoma, Hepatocellular

Data powered by HemOnc (CC BY 4.0) Colophon ⚡